منابع مشابه
Boldly going where no one has gone before.
With all the changes occurring in the U.S. health care system come new opportunities for physician executives willing to boldly go where no one has gone before. These positions are being newly created and thus are somewhat undefined and uncharted. Health care organizations want individuals for high-risk positions with unique skill sets and bright, new ideas. Organizations want to find people wh...
متن کاملARVs: The Next Generation. Going Boldly Together to New Frontiers of HIV Treatment
New antiretrovirals (ARVs), particularly the potentially ‘‘game-changing’’ ARV dolutegravir, offer major potential to meet the compelling need for simpler and better HIV treatment for tens of millions of people in the coming decade. Advantages include substantially lower manufacturing cost, fewer side effects, and less risk of resistance. But key obstacles must be addressed in order to develop ...
متن کاملBoldly Targeting Kinases without mutations.
and those arising in the context of viral infections remains to be elucidated. These entities share with MBL the indolent course and the low propensity to progress to overt malignancy. Among the patients followed for 5 years, only 17% of them progressed to clinically overt, splenic B-cell lymphoma of MZ origin, and only 3 needed treatment over the follow-up time. It is likely that CBL-MZ repres...
متن کاملPersonality Science: Exploring Boldly, Integrating Creatively
that members of one guild will not be on speaking terms with those of another. But the integrative aspirations of personality science will require theories that explicitly seek to bridge the isolated islands of research and this will require an ecumenical attitude toward colleagues of diverse faiths. We now have several metatheoreti-cal frameworks for personality science that will remain an imp...
متن کاملArthritis in space and time--to boldly go!
Despite the profound impact of biologics on the treatment of rheumatoid arthritis (RA), long lasting disease remission remains elusive. We propose that this is a consequence of failing to target the right molecular pathway in the most relevant patient group at the appropriate time and place in disease progression. A limitation to testing this approach is the availability of disease models repre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 1982
ISSN: 0028-0836,1476-4687
DOI: 10.1038/297622e0